The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.90% slipped 1.84% to $55.56 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.04% falling 0.91% to 15,043.97 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.45% falling 0.48% to 34,584.88. The ADR's fall snapped a two-day winning streak. AstraZeneca PLC ADR closed $5.37 short of its 52-week high ($60.93), which the company achieved on July 12th.
The ADR underperformed when compared to some of its competitors Friday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.00% fell 0.32% to $107.73, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.45% rose 0.93% to $219.38, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.29% rose 0.39% to $71.61. Trading volume (7.0 M) remained 4.0 million below its 50-day average volume of 10.9 M.